11
David Archer, John W Howard, Douglas L Henson, Larry D Birch: Mudflap assembly. Fontaine Spray Suppression Co, Ann I Dennen, J Mark Bledsoe, Lanier Ford Shaver & Payne P C, March 22, 2011: US07909343 (7 worldwide citation)

A mudflap assembly comprising a bracket for connection to a vehicle and a hanger extended therefrom. A mudflap is connected to one end of the hanger, while the bracket rotatable receives the other end and maintains the hanger in an initial resting position until the hanger is acted upon by a suffici ...


12
David Archer: Card holder and dispenser. Archer Design, Salter & Michaelson, December 5, 2000: US06155456 (6 worldwide citation)

A card holder and dispensing device includes a housing defining a cavity for receiving a plurality of cards therein. The front wall of the housing has an opening formed therein for loading and removing cards from the cavity of the housing, and the top wall of the housing functions as an exit rail fo ...


13
Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao: Pyrrolidones with anti-hiv activity. Irm, Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037784 (6 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of p ...


14
He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry: Oxindoles with anti-hiv activity. Irm, The Scripps Research Institute, He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry, FITTING Thomas, May 6, 2004: WO/2004/037247 (2 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using oxindoles and compounds related to oxindoles. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of prophyl ...


15
He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer: Azolopyrimidines as inhibitors of cannabinoid 1 activity. Irm, He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer, REID Scott W, October 25, 2007: WO/2007/120454 (2 worldwide citation)

The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


16
Nicholas David Archer: Electrical signal pre-conditioning. Filtronic, Marc Karish, Sheldon Mak Rose & Anderson, February 12, 2008: US07330704 (1 worldwide citation)

A method and circuitry for pre-conditioning an electrical signal. The method comprises limiting the strength of the signal to not exceed a limit signal strength corresponding to the onset of substantial non-linear response of an amplifier to which the limited signal is to be supplied for amplificati ...


17
Molteni Valentina, Li Xiaolin, Nabakka Juliet, Ellis David Archer, Anaclerio Beth, Saez Enrique, Wityak John: Compounds and compositions as lxr modulators. Irm, Molteni Valentina, Li Xiaolin, Nabakka Juliet, Ellis David Archer, Anaclerio Beth, Saez Enrique, Wityak John, REID Scott W, August 25, 2005: WO/2005/077124 (1 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).


18
Hong Liu, Xiaohui He, Ha Soon Choi, Kunyong Yang, David Woodmansee, Zhicheng Wang, David Archer Ellis, Baogen Wu, Yun He, Truc Ngoc Nguyen: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. IRM, Chihang Amy Smith, Genomics Institute of the Novartis Research Foundation, April 17, 2012: US08158634

The invention provides compounds having Formula Ia, or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and Y are as defined in the specification; as well as pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or di ...


19
Baogen Wu, Yun He, Truc Ngoc Nguyen, Kelli L Kuhen, David Archer Ellis, Tao Jiang, Xiaohui He, Kunyong Yang, Badry Bursulaya: Pyrrolidones with anti-HIV activity. IRM, Emily Tongo Wu, Genomics Institute of the Novartis Research Foundation, February 24, 2009: US07495016

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of p ...


20
Xiaohui He, Kunyong Yang, Hong Liu, David Archer Ellis: Azolopyrimidines as inhibitors of cannabinoid 1 activity. IRM, Chihang Amy Smith, Genomics Institute of the Novartis Research Foundation, May 13, 2014: US08722691

The invention provides compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). The compounds are of the Formulae Ia, Ic, Ig and Ik: